GAMMA Investing’s Purple Biotech PPBT Stock Holding History

GAMMA Investing’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-108	Closed	-$436	–	4210
2026 Q1	$436	Sell	108 -176	-62%	-$950	﹤0.01%	3969
2025 Q4	$1.86K	Sell	284 -981	-78%	-$7.12K	﹤0.01%	3624
2025 Q3	$7.27K	Buy	1,265 +822	+186%	+$14.7K	﹤0.01%	3029
2025 Q2	$10.4K	Buy	+443	New	+$11K	﹤0.01%	2780

GAMMA Investing's PPBT Position: Q2 2026 in Review

GAMMA Investing sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 108 shares — an estimated $436 sold.

GAMMA Investing first reported a position in PPBT in Q2 2025 and held it in 4 quarters. The position peaked at $10.4K in Q2 2025. 0 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

GAMMA Investing reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
GAMMA Investing sold 108 Purple Biotech shares in Q2 2026, an estimated $436.
GAMMA Investing first reported a position in Purple Biotech in Q2 2025 and held it in 4 quarters.
GAMMA Investing's Purple Biotech position peaked at $10.4K in Q2 2025.
0 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.